NPSD Tablet
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.
MFDS item code 201904458 · Approved 2019.06.28
This product's status changed to Approval withdrawn on 2024.02.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (including ulcers, gastritis, and reflux esophagitis); prevention of Mendelson syndrome
This medication is used for various gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered before anesthesia to prevent Mendelson's syndrome and is effective in treating ulcers that may occur post-surgery. It is used for gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This medication helps alleviate symptoms and aids in treatment by controlling gastric acid secretion.
○ Adults Usually, regardless of meals, administer 1 tablet orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is preferable to also administer 1 tablet on the night before surgery.
This medication should not be used in patients undergoing dialysis or with kidney dysfunction. It should not be administered to individuals allergic to this drug or its ingredients. Patients who have had a rare disease called acute porphyria should be cautious as this medication can induce seizures. It is not administered to patients who have undergone upper gastrointestinal surgery, pregnant women, women who could become pregnant, and premature infants or newborns. Patients on a restricted potassium diet are advised not to use this medication. Caution is advised in patients with liver dysfunction, history of drug allergies, elderly patients, and those with a history of kidney disease. Regular monitoring is required for elderly patients or those with a history of peptic ulcers when taken in conjunction with NSAIDs. This medication can obscure symptoms of stomach cancer, so gastric ulcer patients or middle-aged patients with newly occurring dyspeptic symptoms should use it only after confirming malignancy. Patients with gastric or duodenal ulcers infected with Helicobacter pylori require eradication therapy. Severely ill patients in intensive care units, those with hypophosphatemia, or patients who have difficulty swallowing also require caution with this medication. Rarely, anaphylactic shock or hypersensitivity reactions such as skin rashes, hives, and breathing difficulties may occur, and if such symptoms develop, administration should be stopped immediately. Blood cell counts may decrease or liver function may change, so patients should undergo examination if they experience symptoms like fatigue, bleeding, or fever. Neurological symptoms such as cardiac rhythm disturbances, vasculitis, gastrointestinal symptoms, dizziness, drowsiness, confusion, and depression have also been reported. Rare side effects include gynecomastia, erectile dysfunction, myalgia, skin rashes, and alopecia. Long-term use of this medication is not recommended, and periodic checks of blood, liver, and kidney function should be conducted during treatment. Elderly patients, those with chronic respiratory diseases, diabetes, and immunocompromised individuals may have an increased risk of pneumonia and should exercise caution. Patients should avoid driving or operating dangerous machinery if they feel dizzy or drowsy after taking this medication. This medication may interact with other drugs, especially anticoagulants or certain antibiotics, so it should be discussed with medical personnel. It is safer for pregnant or breastfeeding women not to take this medication. Safety in children has not been established and thus should not be used. In cases of overdose, emergency treatments such as vomiting or gastric lavage may be necessary, and blood dialysis can also remove the drug. This medication can reduce gastric acid secretion, potentially promoting bacterial growth in the stomach, so eye examinations may be needed for long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help retain the medication's effectiveness over time.
Greenish rectangular film-coated tablet
10 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.